Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Prepaid Assets (2016 - 2026)

United Therapeutics' Prepaid Assets history spans 17 years, with the latest figure at $248.9 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 46.67% to $248.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $248.9 million, a 46.67% increase, with the full-year FY2025 number at $248.9 million, up 46.67% from a year prior.
  • Prepaid Assets hit $248.9 million in Q4 2025 for United Therapeutics, down from $252.2 million in the prior quarter.
  • Over the last five years, Prepaid Assets for UTHR hit a ceiling of $252.2 million in Q3 2025 and a floor of $49.7 million in Q1 2021.
  • Historically, Prepaid Assets has averaged $153.3 million across 5 years, with a median of $162.1 million in 2022.
  • Biggest five-year swings in Prepaid Assets: soared 118.33% in 2022 and later dropped 24.18% in 2023.
  • Tracing UTHR's Prepaid Assets over 5 years: stood at $100.4 million in 2021, then skyrocketed by 118.33% to $219.2 million in 2022, then decreased by 24.18% to $166.2 million in 2023, then rose by 2.11% to $169.7 million in 2024, then soared by 46.67% to $248.9 million in 2025.
  • Business Quant data shows Prepaid Assets for UTHR at $248.9 million in Q4 2025, $252.2 million in Q3 2025, and $229.7 million in Q2 2025.